Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Genitourinary System Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Carcinoma
Genitourinary System Carcinoma

Subtype

Genitourinary System Carcinoma

CI-CAN-00000925Explore in graph →

1,496 active trials44 approved drugs143 evidence items

NCIt: C164141

Overview
Statistics
Survival
Genomics108
Variants & evidence143
Drugs41
Trials4915
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

4,915 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,496
Recruiting: 778
Ph III recruiting: 85
Growth YoY: +17.5%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

StatusAll Active (any)Completed 1,828 Recruiting 939 Terminated 614 Active Not Recruiting 563 Unknown 485 Not Yet Recruiting 228 Withdrawn 186 Suspended 30 Enrolling By Invitation 20 No Longer Available 10 Approved For Marketing 7 Available 5

PhaseAll Early Phase 1 103 N/A 622 Phase 1 1,344 Phase 2 2,128 Phase 3 388 Phase 4 60

No study matches these filters